DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Symbicort (Budesonide Inhalation) - Published Studies


Symbicort Related Published Studies

Well-designed clinical trials related to Symbicort (Budesonide Inhalation)

Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. [2013]

Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler(R) in Japanese Patients with Asthma: A Randomized, Double-Blind, Crossover, Active Comparator-Controlled, Phase III Study. [2012.01.01]

A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain. [2011.10]

Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial. [2011.09]

Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. [2011.08]

Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting. [2011.07]

Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. [2011.07]

Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide. [2011.04]

Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD. [2011.02]

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. [2011.01]

Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology. [2010.11]

Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. [2010.10]

Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study. [2010.09]

Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD. [2010.09]

Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy. [2010.09]

Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. [2010.08]

Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. [2010.05.28]

Ketotifen versus inhaled budesonide for controlling childhood asthma. [2010.05]

Aerosolized L-epinephrine vs budesonide for post extubation stridor: a randomized controlled trial. [2010.04.07]

Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. [2010.02]

Skin thickness in children treated with daily or periodical inhaled budesonide for mild persistent asthma. The Helsinki early intervention childhood asthma study. [2010.02]

The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter. [2010.01]

Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma. [2010.01]

Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. [2010]

Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial. [2010]

The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. [2009.12]

The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. [2009.10.31]

Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. [2009.10.15]

An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice. [2009.09.19]

[Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation] [2009.09]

An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice. [2009.09]

Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. [2009.08]

Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. [2009.05]

High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. [2009.04]

Effect of formoterol with or without budesonide in repeated low-dose allergen challenge. [2009.04]

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. [2009.02.19]

A proof-of-concept study to evaluate the antiinflammatory effects of a novel soluble cyclodextrin formulation of nebulized budesonide in patients with mild to moderate asthma. [2009.02]

Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. [2009.01.05]

Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. [2009.01]

Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. [2008.11]

Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. [2008.10]

A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma. [2008.10]

Inflammatory and functional effects of increasing asthma treatment with formoterol or double dose budesonide. [2008.10]

Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. [2008.09]

Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children. [2008.09]

Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. [2008.09]

[Efficacy and safety of budesonide inhalation suspension nebulization by mesh nebulizer in Japanese infants and young children with bronchial asthma in 12-week, randomised, open study] [2008.08]

Atomization inhalation of terbutaline and budesonide efficiently improved immunity and lung function of AECOPD patients. [2008.08]

Effect of disease duration on dose-response of inhaled budesonide in asthma. [2008.07]

Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]

Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers. [2008.05]

The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. [2008.05]

Long-term effects of budesonide on inflammatory status in COPD. [2008.04]

Bronchodilation of formoterol administered with budesonide: Device and formulation effects. [2008.03]

Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? [2008.01]

Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study. [2008]

Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects. [2008]

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. [2007.11]

Plasma concentrations of fluticasone propionate and budesonide following inhalation: effect of induced bronchoconstriction. [2007.10]

Montelukast vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. [2007.10]

Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]

Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. [2007.08]

The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonide. [2007.08]

Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control. [2007.08]

Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]

A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. [2007.06]

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. [2007.05]

Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. [2007.04]

Potency ratio fluticasone propionate (Flixotide Diskus)/budesonide (Pulmicort Turbuhaler). [2007.03]

The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. [2007.02]

Once versus twice daily budesonide metered-dose inhaler in children with mild to moderate asthma: effect on symptoms and bronchial responsiveness. [2007.01]

Ciclesonide is more effective than budesonide in the treatment of persistent asthma. [2007]

Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study. [2006.12.04]

Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. [2006.12]

Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. [2006.12]

Effectiveness of early budesonide intervention in Caucasian versus Asian patients with asthma: 3-year results of the START study. [2006.11]

Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study. [2006.10]

Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. [2006.09]

Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. [2006.09]

Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. [2006.08.26]

Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation. [2006.08]

EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma. [2006.07]

Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation. [2006.07]

Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics. [2006.06.19]

A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma. [2006.06]

Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. [2006.06]

Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study. [2006.05]

Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma. [2006.05]

Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma. [2006.05]

Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study. [2006.05]

Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial. [2006.05]

Activity of budesonide on nasal neutrophilic inflammation and obstruction in children with recurrent upper airway infections. A preliminary investigation. [2006.03]

Adjustable maintenance dosing with budesonide/formoterol or budesonide: double-blind study. [2006.03]

Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. [2006.02]

Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD. [2006.02]

Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. [2006.01.24]

The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler. [2006.01]

Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. [2006]

Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma. [2006]

Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. [2006]

Clinical effectiveness of nebulised budesonide in the treatment of acute asthma attacks. [2006]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017